Bruce G. Allen Investments’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$236K Sell
672
-80
-11% -$28.5K 0.15% 70
2025
Q4
$246K Buy
752
+16
+2% +$5.08K 0.17% 67
2025
Q3
$208K Sell
736
-13
-2% -$3.77K 0.15% 75
2025
Q2
$209K Hold
749
0.16% 71
2025
Q1
$233K Buy
749
+158
+27% +$46.7K 0.18% 66
2024
Q4
$154K Hold
591
0.13% 99
2024
Q3
$190K Sell
591
-16
-3% -$5.23K 0.15% 79
2024
Q2
$190K Sell
607
-48
-7% -$14.1K 0.16% 75
2024
Q1
$186K Sell
655
-67
-9% -$19.6K 0.15% 84
2023
Q4
$208K Buy
+722
New +$197K 0.19% 73

Other funds holding AMGN

Bruce G. Allen Investments's AMGN Position: Q1 2026 in Review

Bruce G. Allen Investments reduced its Amgen (AMGN) stake by 11% in Q1 2026, selling an estimated $28.5K and leaving 672 shares worth $236K. The position accounts for 0.15% of the portfolio, ranked #70.

Bruce G. Allen Investments first reported a position in AMGN in Q4 2023 and has held it in 10 quarters since. The position peaked at $246K in Q4 2025. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Bruce G. Allen Investments held 672 shares of Amgen worth $236K as of Q1 2026.
  • Bruce G. Allen Investments sold 80 Amgen shares in Q1 2026, an estimated $28.5K.
  • Amgen made up 0.15% of Bruce G. Allen Investments's portfolio in Q1 2026, its #70 holding.
  • Bruce G. Allen Investments first reported a position in Amgen in Q4 2023 and has held it in 10 quarters since.
  • Bruce G. Allen Investments's Amgen position peaked at $246K in Q4 2025.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Bruce G. Allen Investments's 13F filing for Q1 2026, filed 8 May 2026.